Wolverine is engineered as a dual-action regenerative peptide matrix, combining the gastric pentapeptide BPC-157 with the actin-sequestering peptide TB-500 (Thymosin Beta-4) to facilitate advanced research into compound tissue repair and cellular migration pathways.
Angiogenesis & Microvascular Repair (BPC-157): Upregulates VEGFR2 expression and nitric oxide pathways, optimizing investigation into tendon, ligament, and gastrointestinal mucosal healing.
Actin Cytoskeleton Remodeling (TB-500): Binds to globular actin (G-actin) to promote cell migration, microvascular growth, and tissue remodeling across skeletal muscle and dermal matrices.
While monotherapies isolate individual healing mechanisms, the Wolverine blend co-activates local microvascular sprouting and systemic cell migration—allowing researchers to investigate compound extracellular matrix repair and accelerated tissue restoration without administering multiple independent agents.
Disclaimer: This product is sold strictly for research purposes only. Not for human consumption, clinical trials, or therapeutic use.